17 septiembre 2013

PharmaMar en el European Cancer Congress , 17th ECCO - 38th ESMO - 32nd ESTRO . AMSTERDAM, 27 SEPTEMBER - 1 OCTOBER 2013 .

In partnership: European Cancer Congress - Ecco

Accrued Point Ranking (APR) Table :

1 Novartis Oncology 2 466
2 Roche (F. Hoffmann-La Roche Ltd) 2 434
3 Pfizer Inc. 1 871
4 Amgen 1 671
5 Merck Serono 1 467
6 Bristol-Myers Squibb 1 335
7 Bayer Pharma 1 245
8 Sanofi-aventis 829
9 Celgene 784
10 GSK 759
11 AstraZeneca 757
12 Lilly Oncology 694
13 Boehringer Ingelheim Int. GmbH 604
14 MSD Oncology 560
15 Janssen Pharmaceuticals 470
16 Teva (Cephalon) 446
17 PharmaMar 443
18 EISAI 318
19 Vifor Pharma 281
20 Astellas Pharma Europe 267
21 PRIME Oncology 265
22 Helsinn Healthcare SA 243
23 Hospira UK Ltd 221
24 Pierre Fabre Medicament 212
25 Takeda 198
26 Dendreon Corporation 189
27 Archimedes Pharma 155
28 Baxter 151
29 Elekta 128
30 Daiichi Sankyo 126
31 Spepharm 125
32 Varian Medical Systems International AG 124
33 Sigma-Tau 119
34 Pharmacosmos 107
35 Sirtex Medical Europe GmbH 82
36 Qiagen GmbH 78
37 IBA 76

... Hasta un Total de 164 compañias .